Wednesday, April 22, 2026
29.4 C
Bengaluru

Soft Power and the Physician

[wpfilebase tag=file id=92 tpl=download-button /]

Inside this Issue

1. Is Indian Pharma GST-Ready? interview with Sunil Attavar
The state of Indian Pharma’s readiness for the GST regime

2. The Truth About Doctors: Executive Summary by McCann Health
The Truth About Doctors, is a new global study conducted by McCann Health, in partnership with McCann Truth Central. This landmark study surveyed nearly 2,000 doctors in 16 markets

3. Leadership Begins with Self-Awareness by K. Hariram
To become the leader that you want to be, first become aware about the kind of leader you are

4. In Brand Positioning, Focus is Key to Success by Vivek Hattangadi
Too broad a focus when positioning your brand may broaden its reach, but dilute its effectiveness

5. News from Around the Web by MedicinMan

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img
Previous article
Next article